D Gomika Udugamasooriya

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. pmc GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
    Kristi D Lynn
    Division of Surgical Oncology, Department of Surgery, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 76259, USA
    BMC Cancer 10:397. 2010

Detail Information

Publications1

  1. pmc GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
    Kristi D Lynn
    Division of Surgical Oncology, Department of Surgery, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 76259, USA
    BMC Cancer 10:397. 2010
    ..We have reported previously the development of an antagonistic VEGFR2 peptoid (GU40C4) that has promising anti-angiogenic activity in vitro and in vivo...